Pregled bibliografske jedinice broj: 731603
The TREAT-NMD Duchenne Muscular Dystrophy Registries : Conception, Design, and Utilization by Industry and Academia
The TREAT-NMD Duchenne Muscular Dystrophy Registries : Conception, Design, and Utilization by Industry and Academia // Human mutation, 34 (2013), 11; 1449-1457 doi:10.1002/humu.22390 (recenziran, članak, stručni)
CROSBI ID: 731603 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The TREAT-NMD Duchenne Muscular Dystrophy Registries : Conception, Design, and Utilization by Industry and Academia
Autori
Bladen, Catherine L. ; Rafferty, Karen ; Straub, Volker ; Monges, Soledad ; Moresc, Angélica ; Daekins, Hugh ; Roy, Anna ; Chamova, Teodora ; Guergueltcheva, Velina ; Korngut, Lawrence ; Campbell, Craig ; Dai, Yi ; Barišić, Nina ; Kos, Tea ; Brabec, Petr ; Rahbek, Jes ; Lahdetiel, Jaana ; Tuffery-Giraud, Sylvie ; Claustres, Mireille ; Leturcq, France ; Yaou, Rabah Ben ; Walter, Maggie C. ; Schreiber, Olivia ; Karcagi, Veronika ; Herczegfalvis, Agnes ; Viswanathan, Venkatarman ; Bayat, Farhad ; Isis de la caridad Guerrero, Sarmiento ; Ambrosini, Anna ; Ceradini, Francesa ; Kimura, En ; Van den Bergen, Janneke C. ; Rodrigues, Miriam ; Roxburgh, Richard ; Lusakowska, Anna ; Oliveira, Jorge ; Santos, Rosário ; Neagu, Elena ; Butoianu, Niculina ; Artemieva, Svetlana ; Milic Rasic, Vedrana ; Posada, Manuel ; Palau, Frances ; Lindvall, Bjorn ; Bloetzer, Clame ; Karaduman, Ayse ; Topaloğlu, Haluk ; Inal, Serap ; Oflazer, Piraye ; Stringer, Angela ; Shatillo, Andri V ; Martin, Ana S ; Peay, Holly ; Flanigan, Kevin M ; Salgado, David ; Rekowski, Brigitta ; Lynn, Stephen ; Heslop, Emma ; Gainotti, Sabina ; Taruscio3, Domenica ; Kirschner, Jan ; Verschuuren, Jan ; Bushby, Kate ; Béroud ; Christophe ; Lochmüller, Hanns
Izvornik
Human mutation (1059-7794) 34
(2013), 11;
1449-1457
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, stručni
Ključne riječi
Duchenne muscular dystrophy; TREAT NMD
(Duchenne muscular dystrophy; dystrophin; therapy; patient registries)
Sažetak
Duchenne muscular dystrophy (DMD) is an X-linked genetic disease, caused by the absence of the dystrophin protein. Although many novel therapies are under development for DMD, there is currently no cure and affected individuals are often confined to a wheelchair by their teens and die in their twenties/thirties. DMD is a rare disease (prevalence <5/10, 000). Even the largest countries do not have enough affected patients to rigorously assess novel therapies, unravel genetic complexities, and determine patient outcomes. TREAT-NMD is a worldwide network for neuromuscular diseases that provides an infrastructure to support the delivery of promising new therapies for patients. The harmonized implementation of national and ultimately global patient registries has been central to the success of TREAT-NMD. For the DMD registries within TREAT- NMD, individual countries have chosen to collect patient information in the form of standardized patient registries to increase the overall patient population on which clinical outcomes and new technologies can be assessed. The registries comprise more than 13, 500 patients from 31 different countries. Here, we describe how the TREAT-NMD national patient registries for DMD were established. We look at their continued growth and assess how successful they have been at fostering collaboration between academia, patient organizations, and industry.
Izvorni jezik
Engleski
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE